Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism: a Monocentric Cohort Study With Patient Reported Outcome

NCT04948684 is registered in ClinicalTrials.gov with Hospital Avicenne as lead sponsor.

NCT NCT04948684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04948684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism: a Monocentric Cohort Study With Patient Reported Outcome
Lead sponsor
Hospital Avicenne
Phase
Observational
Overall status
Completed
Start date
September 1, 2017
Completion date
February 11, 2021
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical parkinsonism, dystonia, parkinson disease